Outlook Therapeutics Stock Climbs 38% After Winning FDA Appeal For NAMD Therapy
26/5 15:46
(RTTNews) - Shares of Outlook Therapeutics, Inc. (OTLK) are climbing about 38 percent in Tuesday morning trading after the company announced that the U.S. FDA has granted its appeal following completion of the Formal Dispute Resolution process for ONS-5010/LYTENAVA, its investiga...